However, MEG3 may play a pro-fibrosis role because it has been demonstrated to enhance fibrosis and inflammatory responses in diabetic nephropathy through the miR-181a/Egr1/TLR4 axis [29]. Here, MEG3 is linked to diabetic kidney disease.